Jade Biosciences, Inc. (JBIO)
NASDAQ: JBIO · Real-Time Price · USD
6.92
-0.29 (-4.02%)
At close: Jun 5, 2025, 4:00 PM
6.89
-0.03 (-0.43%)
After-hours: Jun 5, 2025, 4:00 PM EDT

Company Description

Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases.

The company was incorporated in 2024 and is headquartered in Waltham, Massachusetts.

Jade Biosciences, Inc.
Jade Biosciences logo
Country United States
Founded 2024
Industry Biotechnology
Sector Healthcare
Employees 30
CEO Tom Frohlich

Contact Details

Address:
221 Crescent Street Building 23, Suite 105
Waltham, Massachusetts 02453
United States
Phone 916 322 1700
Website jadebiosciences.com

Stock Details

Ticker Symbol JBIO
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000947559
CUSIP Number 008064206
ISIN Number US0080642061

Key Executives

Name Position
Tom Frohlich Chief Executive Officer and Director
Jonathan Quick Senior Vice President of Finance
Dr. Andrew James King D.V.M., Ph.D. Chief Scientific Officer and Head of Research & Development
Elizabeth Balta General Counsel and Corporate Secretary
Lori Stewart Senior Vice President of People
Dr. Hetal Kocinsky M.D. Chief Medical Officer
Dr. Jason Wright Ph.D. Senior Vice President, Chemistry, Manufacturing and Controls
Valerie Fauvelle Senior Vice President of Regulatory and Quality
Amy Sullivan Senior Vice President of Development Operations
Sandy Lewis Senior Vice President, Biometrics and Clinical Strategy